Top 5 This Week

PLAST 2026 Milano: A Landmark Exhibition for Industry Growth

PLAST 2026 Milano: A Landmark Exhibition for Industry Growth  A Global Meeting Point for Plastics...

Building Better Products with the Moretto Model Philosophy

Building Better Products with the Moretto Model Philosophy Moretto is a leading company in the...

Bridging Global Strategy and Local Markets: The Bandera Advantage

Bridging Global Strategy and Local Markets: The Bandera Advantage The presentation highlights a comprehensive overview...

Intelligent Injection Molding Solutions Powered by BMB

  BMB S.p.A. represents nearly six decades of excellence in injection molding technology, with a...
- Advertisement -spot_img

Mylab launches rapid point-of-care dengue tests

[ad_1]

Mylab Discovery Solutions has introduced two rapid point-of-care tests for the detection of dengue infections — rapid gold test and high-accuracy dry luminescence assay test. 

The tests can help determine the stage and progression of the infection.

The point-of-care 15-20 minute test does not require a laboratory setup.

The tests can be used in resource-limited regions to support dengue screening programmes.

Hasmukh Rawal, Co-founder and Managing Director of Mylab, said, “These rapid point-of-care tests provide healthcare professionals with accurate and efficient tools for timely diagnosis, ultimately aiding in effective disease management.”

The tests differentiate between IgM and IgG antibodies. In the case of primary dengue infection, detectable levels of IgM antibodies emerge as early as the third day after infection and generally persist for 2-6 months. Following IgM, dengue IgG antibodies appear around day seven of the fever during the primary infection and remain present for an extended period, potentially lasting for years.



[ad_2]

Source link

Popular Articles